Skip to main content

A clearer way to understand peptides.

Skin & Topical · Comparison method

Peptide Serums: Comparing Formulas Beyond the Label

The short answer

To compare peptide serums, start with the full ingredient list rather than the front label. Check which peptides appear by their INCI names, because trade names such as Matrixyl or Argireline stand for specific ingredients or blends. Note whether a concentration is stated and what it refers to, since a percentage may describe a supplier's ingredient solution rather than pure peptide. Then look at the base formula, pH and packaging, and ask whether any cited study tested this exact product, in people, against a placebo. No single number ranks serums.

  • What we know

    US labels list ingredients from most to least, but those at 1% or less can follow in any order, and peptides are usually used at low levels.

  • What’s uncertain

    How much of any peptide reaches its target in skin from a given formula; few products publish data on this.

  • Watch for

    Trade names without INCI names, percentages that do not say what they measure, and ingredient studies presented as studies of a finished product.

Peptide serums are hard to compare from the front of the box. The useful information sits in the full ingredient list, the product page and any study a brand cites. This guide is a checklist for reading those sources side by side. It does not rank products, and no single number can.

Start with the full ingredient list

In the United States, cosmetic ingredients must be listed from most to least, except that ingredients at 1% or less may follow the rest in any order Source [1]. Labels must use ingredient names set by regulation Source [2], and they do not have to state concentrations Source [3].

That matters for peptides because they are usually used at low levels. When the Cosmetic Ingredient Review expert panel assessed tripeptide-1, related peptides and their metal and fatty-acid forms in 2018, it reported typical use concentrations below 10 parts per million Source [4]. Once you are below the 1% line, the position of a peptide in the list tells you little about how much is there.

Translate trade names into ingredient names

Front labels and marketing often use supplier trade names. The ingredient list uses standardized INCI names, and those are what you should compare:

  • Matrixyl is palmitoyl pentapeptide-4, a five-amino-acid peptide (sequence KTTKS) with a fatty-acid chain attached Source [5].
  • Matrixyl 3000 is a combination of two different peptides with fatty-acid chains: Pal-GHK, listed as palmitoyl tripeptide-1, and the four-amino-acid Pal-GQPR Source [6].
  • Argireline appears as acetyl hexapeptide-8 in the supplier's current ingredient listing Source [7]; some published papers call it acetyl hexapeptide-3 Source [5].
  • GHK-Cu, the best-known copper peptide, is listed as copper tripeptide-1 Source [5].

Two practical points follow. A trade name can stand for a blend, so one name on the front may add two lines to the ingredient list. And similar names are not interchangeable: palmitoyl tripeptide-1 and copper tripeptide-1 are built on the same amino acid sequence but are different ingredients Source [6].

Stated versus unstated concentration

Most peptide serums do not say how much of each peptide they contain. When a percentage does appear, ask what it measures. Some peptide suppliers sell their ingredients as ready-made solutions. Lubrizol, for example, lists its Argireline peptide solution as water, acetyl hexapeptide-8 and caprylyl glycol, and recommends using 2–10% of that solution in a formula Source [7]. A product described as containing a given percentage of a trade-name peptide may therefore be describing the solution, not the pure peptide.

Questions worth putting to a brand: Does the percentage refer to the pure peptide or to the raw material? Is the formula the same in every market? Does the ingredient list on the box match the one online? One brand, for instance, notes on its product page that its online list may differ from the box depending on when and where it was bought Source [8].

Base formula, pH and packaging

Peptides are not easy ingredients. Most anti-wrinkle peptides pass poorly through skin, and formulators use fatty-acid chains, carriers and other approaches to improve that Source [9]. GHK-based peptides, for example, are highly water-soluble, partition poorly into the skin's oily outer layer and are chemically unstable, which complicates formulation Source [6]. For copper peptides specifically, a 2026 review notes that common formula ingredients such as citrate, chelating agents and amino-acid buffers can compete with the peptide for copper, and that skin penetration depends on pH and the vehicle Source [10].

You cannot measure any of this at home, but you can note what is disclosed: a pH range, the type of base (water, oil or emulsion), any carrier technology, storage conditions and a use-by period after opening. Missing information is a gap you can ask about, not proof of a problem.

What a brand's own study can and cannot show

Published peptide trials exist, but they are usually small and tied to one formula:

  • A 12-week, double-blind, split-face study in 93 women compared a moisturizer with and without pal-KTTKS and found greater reduction in fine lines and wrinkles on the peptide side. The study's listed affiliation is Procter & Gamble Source [11].
  • A 4-week randomized trial in 60 people found that roughness measures around the eyes fell with an Argireline preparation but not with placebo Source [12].

Across the field, a 2019 systematic review of matrix-stimulating cosmetic peptides found 15 clinical studies, of which only six used a placebo control and five were double-blind Source [13]. A 2026 meta-analysis of 19 randomized trials of oral and topical peptides found a modest pooled effect on wrinkles that was driven mostly by oral products Source [14]. In drug and device research, industry-sponsored studies more often report favorable efficacy results Source [15], which is a reason to ask who ran a cosmetic study too.

When a brand cites a study, check:

  • What was tested: the finished product you are buying, a similar formula, or the raw ingredient?
  • In whom: people, animals or cells, and how many?
  • Against what: a placebo or vehicle, the other side of the face, or nothing?
  • How it was measured: instruments and blinded graders, or self-assessment only?
  • For how long, and by whom: weeks of use, and who paid for and ran the study?

A supplier's claim about its raw ingredient describes that ingredient in the supplier's test formula. It is not a study of the serum on the shelf.

A simple comparison worksheet

For each serum, write down:

  • Peptides listed, by INCI name, and their positions in the list
  • Any stated concentration, and what it refers to
  • Other notable ingredients and the type of base
  • Stated pH, packaging and storage information
  • Whether a study of this exact product is published, and its design
  • Price per milliliter from the official site, with the date you checked

A row that reads "not stated" is information too. Our documentation review of a copper peptide serum shows this approach applied to one product, and how we evaluate products explains our criteria. For copper peptides specifically, see how to read the evidence.

Reading the evidence

Each row is one claim. A strong result in cells does not upgrade a weak result in people, and a product study tells you about that product.

Evidence by claim. Each row is one claim; select a column heading to sort. (column headings with arrows can be selected to sort)
Fine lines with palmitoyl pentapeptide-4 (pal-KTTKS)Human · 93 women aged 35–55, 12 weeks, split-faceSame moisturizer without the peptideGreater reduction in wrinkles and fine lines on the peptide side by image analysis and expert grading; subjects also reported improvement.One study with a Procter & Gamble affiliation, testing one formula; results may not apply to other products.[11]
Periorbital wrinkles with ArgirelineHuman · 60 participants randomized 3:1, 4 weeksPlaceboRoughness measures on skin replicas fell in the Argireline group and not in the placebo group.Short; with 3:1 allocation, the placebo group was about 15 people; one formulation in one population.[12]
How matrix-stimulating cosmetic peptides are testedHuman · 15 clinical studies in 12 papersPlacebo in 6 of 15 studiesOnly five studies were double-blind; nine enrolled women only; most relied on image-based assessment.A review of study methods, not a pooled estimate of benefit.[13]
Peptides for skin aging, pooledHuman · 19 randomized trials, 1,341 participantsPlacebo or vehicleModest pooled effect on wrinkles, driven mostly by oral products; effects on elasticity and density were inconsistent.Combines oral and topical products and many different peptides, so it cannot rate any single serum.[14]

Product context

Market
United States
Form
Cosmetic serum
Route
Topical
Status
Cosmetics other than color additives need no FDA approval before sale. Labels must list ingredients by names set in regulation but need not state amounts.

Status checked . Status applies to this product form only.

Questions people ask

Is a serum with more peptides better than one with a single peptide?

Not on that basis alone. Each peptide has its own, usually small, evidence base, and a long list does not show that any of them is present at a level that was tested.

Why do Argireline products show two different ingredient names?

Some published papers use acetyl hexapeptide-3, while the supplier's current listing uses acetyl hexapeptide-8. Both are used for the ingredient sold as Argireline, so look for either name.

What does "clinically tested" mean on a serum?

Only that some test was run. Ask whether it tested the finished product or an ingredient, in how many people, against what comparison, for how long, and whether the results are published.

Is price per bottle a fair comparison?

Price per milliliter is more comparable across bottle sizes, but it says nothing about how much of any peptide a product contains.

Sources

  1. 21 CFR 701.3 - Designation of ingredients Electronic Code of Federal Regulations.

    Regulator documentAccessed

  2. Summary of Cosmetics Labeling Requirements U.S. Food and Drug Administration, 2025.

    Regulator documentAccessed

  3. Cosmetics Labeling Guide U.S. Food and Drug Administration, 2022.

    Regulator documentAccessed

  4. Johnson W, Bergfeld WF, Belsito DV, et al.. Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics International Journal of Toxicology (record in the Penn State research portal), 2018.

    Journal articleOtherDOI 10.1177/1091581818807863Accessed

  5. Pintea A, Manea A, Pintea C, et al.. Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review Biomolecules, 2025.

    Journal articleNarrative reviewPMID 39858482DOI 10.3390/biom15010088Accessed

  6. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective BioImpacts, 2025.

    Journal articleNarrative reviewPMID 39963574DOI 10.34172/bi.30071Accessed

  7. Argireline peptide solution C Lubrizol, 2026.

    Product label or listingAccessed

  8. Multi-Peptide + Copper Peptides 1% Serum (US product page) The Ordinary (DECIEM), 2026.

    Product label or listingAccessed

  9. Mortazavi SM, Moghimi HR. Skin permeability, a dismissed necessity for anti-wrinkle peptide performance International Journal of Cosmetic Science, 2022.

    Journal articleNarrative reviewPMID 35302659DOI 10.1111/ics.12770Accessed

  10. Robinson LR, Fitzgerald NC, Doughty DG, et al.. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin International Journal of Cosmetic Science, 2005.

    Journal articleRandomized controlled trialPMID 18492182DOI 10.1111/j.1467-2494.2005.00261.xAccessed

  11. Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study American Journal of Clinical Dermatology, 2013.

    Journal articleRandomized controlled trialPMID 23417317DOI 10.1007/s40257-013-0009-9Accessed

  12. Michalek IM, Lelen-Kaminska K, Caetano Dos Santos FL. Peptides stimulating synthesis of extracellular matrix used in anti-ageing cosmetics: Are they clinically tested? A systematic review of the literature Australasian Journal of Dermatology, 2019.

    Journal articleSystematic reviewPMID 30941744DOI 10.1111/ajd.13036Accessed

  13. Nukaly HY, Halawani IR, Irtaza HM, et al.. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials Frontiers in Medicine, 2026.

    Journal articleMeta-analysisPMID 41924746DOI 10.3389/fmed.2026.1618306Accessed

  14. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome Cochrane Database of Systematic Reviews, 2017.

    Journal articleSystematic reviewPMID 28207928DOI 10.1002/14651858.MR000033.pub3Accessed

Update log

  • CheckedFirst published.
Spot an error?Suggest a correction →Content ID PA-0015

This content explains published research and product categories. It does not provide personal medical advice.